The fight over breast-cancer treatment with Roche's Avastin has come to a head: U.S. officials decided to revoke the drug's indication for breast cancer, and European Medicines Agency moved to restrict it for use with only one type of chemotherapy.
The decisions stand to cut more than $1 billion off Avastin's $6 billion in annual revenues, and they're sure to draw fire from folks who've been advocating for the drug.
Health Glance
Yogurt’s good for you -- but apparently not quite as good as Dannon says it is. The yogurt maker will pay out $21 million to settle charges of deceptive advertising that it overstated health benefits for Activia and DanActive yogurt products, according to the Federal Trade Commission.
A federal district judge in Virginia ruled on Monday that the keystone provision in the Obama health care law is unconstitutional, becoming the first court in the country to invalidate any part of the sprawling act and ensuring that appellate courts will receive contradictory opinions from below.





























